Medical Treatment & Prevention

Description

No matching items found.

People

  

  

  

1 of 8

  

  

  

• ALUCK THIPAYARAT
• BOONSERM KAEWKAMNERDPONG
• CHANYAPORN BSTIELER
• DUANGHATHAI WIWATRATANA
• DUJDUAN WARAHO

Publications

  

  

  

16 of 17

  

  

  

• ● The neurodevelopment of value-driven attention; Praewpiraya Wiwatphonthana, Panchalee Sookprao, Chaipat Chunharas, et al.; 2021; Poster
• ● Transcriptional signature genes associated with synapse, mitochondria, and cytoskeleton of hippocampal and entorhinal cortex neurons in Alzheimer’s brain; Supatha Aimauthon and Poommaree Namchaiw; 2022; Poster
• ● Transformation of a traditional micromanipulator to a semi-automatic cell surgery robotic system for In-Vitro fertilization; K. Thamrongaphichartkul;S. Vongbunyong;L. Nuntakarn; 2020; Journal article
• ● Translation and psychometric testing of the Thai version of Cancer Survivors’ Unmet Needs measure among cancer survivors; Pichitra Lekdamrongkul; Kanaungnit Pongthavornkamol; Alex Molassiotis; Porntip Dechpichai; Pimchan Pinsuntorn; 2022; Journal article
• ● Trends in prevalence and antibiotic non-susceptibility of Acinetobacter baumannii–calcoaceticus complex in Thailand (2000–2022): A secondary data analysis; Panisara Kasemteerasomboon, Wiriya Mahikul, Nontaphat Leerach, et al.; 2025; Journal article

Projects

  

  

  

1 of 3

  

  

  

• ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
• ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
• ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
• ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
• ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering